Wellington Management Group LLP Amicus Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$531 Billion
Q4 2024

A detailed history of Wellington Management Group LLP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 28,461,994 shares of FOLD stock, worth $259 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

28,461,994

Previous 23,964,044 18.77%

Holding current value

$259 Million

Previous $256 Million 4.76%

% of portfolio

0.05%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$9.36 - $12.01 $42.1 Million - $54 Million	4,497,950 Added 18.77%	28,461,994 $268 Million
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $27.3 Million - $34.5 Million	2,856,101 Added 13.53%	23,964,044 $256 Million
Q2 2024 Aug 13, 2024	BUY	$9.04 - $11.75 $20.8 Million - $27.1 Million	2,304,298 Added 12.25%	21,107,943 $209 Million
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $215 Million - $268 Million	18,803,645 New	18,803,645 $222 Million
Q4 2023 Feb 12, 2024	BUY	$9.97 - $14.52 $151 Million - $221 Million	15,190,024 New	15,190,024 $216 Million
Q3 2023 Nov 14, 2023	SELL	$11.78 - $13.86 $3.49 Million - $4.11 Million	-296,607 Reduced 3.79%	7,523,689 $91.5 Million
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $3.27 Million - $4.06 Million	305,255 Added 4.06%	7,820,296 $98.2 Million
Q1 2023 May 12, 2023	SELL	$10.91 - $13.54 $6.46 Million - $8.02 Million	-592,306 Reduced 7.31%	7,515,041 $83.3 Million
Q4 2022 Feb 13, 2023	BUY	$9.89 - $12.7 $504,113 - $647,344	50,972 Added 0.63%	8,107,347 $99 Million
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $29.1 Million - $37.8 Million	-2,968,369 Reduced 26.92%	8,056,375 $84.1 Million
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $97.2 Million - $173 Million	-15,594,363 Reduced 58.58%	11,024,744 $118 Million
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $233,283 - $368,996	-29,567 Reduced 0.11%	26,619,107 $252 Million
Q4 2021 Feb 11, 2022	BUY	$9.82 - $12.44 $23.1 Million - $29.3 Million	2,352,976 Added 9.68%	26,648,674 $308 Million
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $75.4 Million - $102 Million	8,624,249 Added 55.03%	24,295,698 $232 Million
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $13.6 Million - $16.8 Million	1,563,477 Added 11.08%	15,671,449 $151 Million
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $36.5 Million - $94.8 Million	3,971,505 Added 39.18%	14,107,972 $139 Million
Q4 2020 Feb 12, 2021	BUY	$13.47 - $24.89 $55.7 Million - $103 Million	4,133,312 Added 68.85%	10,136,467 $234 Million
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $9.28 Million - $11.4 Million	-720,136 Reduced 10.71%	6,003,155 $84.8 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $18.1 Million - $32 Million	2,042,114 Added 43.62%	6,723,291 $101 Million
Q1 2020 May 14, 2020	SELL	$6.63 - $11.16 $2.3 Million - $3.87 Million	-347,164 Reduced 6.9%	4,681,177 $43.3 Million
Q4 2019 Feb 11, 2020	BUY	$7.48 - $10.75 $37.6 Million - $54.1 Million	5,028,341 New	5,028,341 $49 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

311M

Call Options Held

467K

Put Options Held

515K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.56B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Amicus Therapeutics, Inc. Transaction History